Amedisys, Inc. (NASDAQ:AMED) Expected to Post Earnings of $1.17 Per Share

07:56pm, Tuesday, 16'th Nov 2021 Dakota Financial News
Wall Street analysts expect Amedisys, Inc. (NASDAQ:AMED) to report earnings of $1.17 per share for the current quarter, Zacks reports. Seven analysts have issued estimates for Amedisys earnings. The highest EPS estimate is $1.25 and the lowest is $1.13. Amedisys posted earnings of $1.49 per share in the same quarter last year, which would suggest []
Related Stocks: AMED , BFAM , COUP , DAR , GO , LFUS , APPN , CCCS , SWIM , FA , WSO , ROLL , STMP , OUT , LSTR , PRLB , PLUG , TPIC ,
DBMR has added a new report titled Unskilled Home Healthcare Market with data Tables for historical and forecast years represented with Chats & Graphs spread through Pages with easy to understand detailed analysis. The credible report comprises of the market

New Strong Sell Stocks for November 5th

12:58pm, Friday, 05'th Nov 2021
BLMN, AMED, HL, LGIH, and PLMR have been added to the Zacks Rank #5 (Strong Sell) List on November 5, 2021.
BATON ROUGE, La., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and higher acuity care services, today announced that Paul
Amedisys (AMED) reports better-than-expected earnings for the third quarter on strong growth in the Home Health segment.
Amedisys, Inc's (AMED) CEO Paul Kusserow on Q3 2021 Results - Earnings Call Transcript
Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BATON ROUGE, La., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and higher acuity care services, will report results for th
Last month, we discussed that Amedisys stock price could rebound over a one-month period after falling 3% in a week, based on its historical performance. However, AMED stock has seen a further decline
BATON ROUGE, La., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice and personal care, has signed a definitive agreement to acquire r
EHC vs. AMED: Which Stock Is the Better Value Option?
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?
Investors can capitalize on Democratic spending no matter their affiliation. Here are the stocks to buy based on boosts in renewables, health care and infrastructure.
The stock price of Amedisys, a home-health and hospice company, reached its 52-week low of $175 in yesterday's trading session. AMED stock has seen a gradual decline from levels of over $310 in Jan an
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE